Chemed Corp. Stock
€520.00
Your prediction
Chemed Corp. Stock
Pros and Cons of Chemed Corp. in the next few years
Pros
Cons
Performance of Chemed Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chemed Corp. | 0.970% | -8.036% | -12.712% | 5.967% | -0.962% | 32.732% | 83.535% |
Amn Healthcare Svs | 2.780% | 2.857% | -5.263% | -30.323% | -19.403% | -17.557% | 16.744% |
Select Medical Holdings | 0.780% | 0.000% | -6.522% | -4.444% | 19.444% | -17.834% | 99.351% |
Neogenomicsinc. | -7.690% | 3.150% | -7.092% | -1.504% | -16.026% | -67.829% | - |
Comments
News
Chemed Reports First-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the